3163-15-3

Basic information

• Product Name: 2-Amino-1,3-benzenediol
• Synonyms: 2-Aminoresorcinol;2-amino-1,3-benzenediol;o-aminoresorcinol;6-BROMO-2,4-DIETHOXY-1-NITROBENZENE;2-aMinobenzene-1,3-diol;1,3-Benzenediol, 2-amino-
• CAS NO: 3163-15-3
• Molecular Formula: C₆H₇NO₂
• Molecular Weight: 125.12528
• EINECS: 1533716-785-6
• Mol File: 3163-15-3.mol

Chemical Properties

• Melting Point: >200 °C (decomp)
• Boiling Point: 292.8 °C at 760 mmHg
• Flash Point: 130.9 °C
• Appearance: /
• Density: 1.412 g/cm³
• Refractive Index: 1.512
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 9.24±0.10(Predicted)
• CAS DataBase Reference: 2-Amino-1,3-benzenediol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Amino-1,3-benzenediol(3163-15-3)
• EPA Substance Registry System: 2-Amino-1,3-benzenediol(3163-15-3)

Safety Data

• Hazardous Substances Data: 3163-15-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-Amino-1,3-benzenediol is used as a key intermediate in the synthesis of various pharmaceutical compounds for its versatile chemical properties, contributing to the development of new drugs and therapeutic agents.
Used in Dye Industry:
As a component in dye production, 2-Amino-1,3-benzenediol is utilized for its ability to form color compounds, playing a crucial role in the creation of a wide range of dyes used in different applications.
Used in Photographic Industry:
2-Amino-1,3-benzenediol is used as a chemical component in photographic developers, where its reactivity and reducing properties aid in the development process of photographic films and papers.
Used in Chemical Synthesis:
2-Amino-1,3-benzenediol is employed as a reagent in the synthesis of various organic and inorganic compounds, leveraging its unique chemical structure to facilitate reactions in the chemical industry.
Used in Antioxidant Research:
2-Amino-1,3-benzenediol is studied for its potential antioxidant properties, which may have applications in health and nutrition, as well as in industrial processes where oxidation can lead to degradation of materials or products.

InChI:InChI=1/C11H15BrO3/c1-4-14-8-6-9(12)11(13-3)10(7-8)15-5-2/h6-7H,4-5H2,1-3H3

Upstream product

• 601-89-8 2-nitroresorcinol 
• 7647-01-0 hydrogenchloride 
• 30616-78-5 2-phenyl-benzooxazol-4-ol 
• 2734-70-5 2,6-dimethoxyaniline 

Downstream Products

• 73713-92-5 4-hydroxybenzo[d]oxazole-2(3H)-thione 
• 861295-58-1 1,3-diacetoxy-2-acetylamino-benzene 
• 3773-91-9 5-hydroxy-3-methyl-benzo[1,4]oxazin-2-one 
• 69589-23-7 di-tert-butyldimethylsilyl-2-aminoresorcinol 
• 437755-82-3 {(S)-1-[Hydroxy-(4-hydroxy-benzooxazol-2-yl)-methyl]-2-methyl-propyl}-carbamic acid benzyl ester 
• 488802-19-3 N-(2,6-dihydroxy-phenyl)-3,5-dinitro-benzamide 
• 476454-38-3 [5-bromo-4-(2,6-dihydroxy-phenylamino)-2-oxo-2H-pyrimidin-1-yl]-acetic acid ethyl ester 
• 476667-23-9 5-bromo-N⁴-(2,6-dihydroxyphenyl)-N¹-(tert-butoxycarbonylmethyl)-cytosine 
• 97773-25-6 benzoic acid-(2,6-dihydroxy-anilide) 
• 867258-35-3 pyridine-2-carboxylic acid (2,6-dihydroxyphenyl)amide 
• 882999-92-0 2-[(Naphthalen-2-ylmethyl)-amino]-benzene-1,3-diol 
• 28955-70-6 4-hydroxybenzo[d]oxazol2(3H)-one 
• 124457-41-6 1-(2,6-dihydroxyphenyl)-imidazole-4-carboxylic acid ethyl ester 
• 1146220-56-5 C₁₆H₁₄N₂O₃ 

Relevant articles and documents

One-pot synthesis of hydroxybenzo[d]- oxazole-2-aliphatic acid derivatives by Meerwein's reagent

(Chemical Equation Presented) A general one-pot synthesis of hydroxylbenzo[d]oxazole-2-aliphatic acid esters and hydroxylbenzo[d]oxazole-2- amino acid esters was successfully achieved in good yield by using Meerwein's reagent. Copyright Taylor & Francis G

Cobalt nanoclusters coated with N-doped carbon for chemoselective nitroarene hydrogenation and tandem reactions in water

The development of active and selective non-noble metal-based catalysts for the chemoselective reduction of nitro compounds in aquo media under mild conditions is an attractive research area. Herein, the synthesis of subnanometric and stable cobalt nanoclusters, covered by N-doped carbon layers as core-shell (Co@NC-800), for the chemoselective reduction of nitroarenes is reported. TheCo@NC-800catalyst was prepared by the pyrolysis of the Co(tpy)2complex impregnated on Vulcan carbon. In fact, the use of a molecular complex based on six N-Co bonds drives the formation of a well-defined and distributed cobalt core-shell nanocluster covered by N-doped carbon layers. In order to elucidate its nature, it has been fully characterized by using several advanced techniques. In addition, this as-prepared catalyst showed high activity, chemoselectivity and stability toward the reduction of nitro compounds with H2and under mild reaction conditions; water was used as a green solvent, improving the previous results based on cobalt catalysts. Moreover, theCo@NC-800catalyst is also active and selective for the one-pot synthesis of secondary aryl amines and isoindolinones through the reductive amination of nitroarenes. Finally, based on diffraction and spectroscopic studies, metallic cobalt nanoclusters with surface CoNxpatches have been proposed as the active phase in theCo@NC-800material.

Ether compound and pharmaceutical application thereof in prevention and treatment of diabetes and metabolic syndrome

The invention relates to an ether compound and a pharmaceutical application thereof in prevention and treatment of diabetes and metabolic syndrome. Specifically, the invention provides a compound as shown in a formula (I), an isomer, a raceme, a prodrug, a solvate, a deuterated substance or a pharmaceutically acceptable salt thereof, and Ar1, Ar2, X, Y and R are defined in the specification.

ALPHA, BETA-UNSATURATED AMIDE COMPOUND

An object of the present invention is to provide an α,β-unsaturated amide compound or a pharmaceutically acceptable salt or the like thereof having anticancer activity and the like. The α,β-unsaturated amide compound represented by the following formula (I) or a pharmaceutically acceptable salt or the like thereof has anticancer activity and the like: [wherein, "A" represents optionally substituted heterocyclic diyl, R1 represents hydrogen atom or optionally substituted lower alkyl, R2 represents optionally substituted aryl, optionally substituted cycloalkyl, optionally substituted aliphatic heterocyclic group or optionally substituted aromatic heterocyclic group, X represents -O-, -S-, -SO2-, -NRX1- (wherein, RX1 represents hydrogen atom or lower alkyl), -CHRX2- (wherein, RX2 represents hydrogen atom or hydroxy), -CH=CH-, -CO- or -NH-CO-, and n1 and n2 are the same or different, and each represents 0 or 1].

PRMT5 INHIBITORS AND USES THEREOF

Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described.

Synthesis and biological evaluation of pyrimidine derivatives as novel human Pin1 inhibitors

Pin1 (Protein interacting with NIMA1) is a cis–trans isomerase and promotes the amide bond rotation of phosphoSer/Thr-Pro motifs in its substrates. Inhibition of Pin1 might be a novel strategy for developing anticancer agents. Herein, a series of pyrimidi

Expanding the Balz–Schiemann Reaction: Organotrifluoroborates Serve as Competent Sources of Fluoride Ion for Fluoro-Dediazoniation

The Balz–Schiemann reaction endures as a method for the preparation of (hetero)aryl fluorides yet is eschewed due to the need for harsh conditions or high temperatures along with the need to isolate potentially explosive diazonium salts. In a departure from these conditions, we show that various organotrifluoroborates (RBF3?s) may serve as fluoride ion sources for solution-phase fluoro-dediazoniation in organic solvents under mild conditions. This methodology was successfully extended to a one-pot process obviating aryl diazonium salt isolation. Sterically hindered (hetero)anilines are fluorinated under unprecedentedly mild conditions in good-to-excellent yields. Taken together, this work expands the repertoire of RBF3?s to act as fluorine ion sources in an update to the classic Balz–Schiemann reaction.

a, ? UNSATURATED AMIDE COMPOUND

The present invention provides an α,β-unsaturated amide compound or a pharmaceutically acceptable salt or the like thereof having anticancer activity and the like represented by the following formula (I): [wherein, "A" represents optionally substituted heterocyclic diyl, R1 represents hydrogen atom or optionally substituted lower alkyl, R2 represents optionally substituted aryl, optionally substituted cycloalkyl, optionally substituted aliphatic heterocyclic group or optionally substituted aromatic heterocyclic group, X represents -O-, -S-, -SO2-, -NRX1- (wherein, RX1 represents hydrogen atom or lower alkyl), -CHRX2- (wherein, RX2 represents hydrogen atom or hydroxy), -CH=CH-, -CO- or -NH-CO-, and n1 and n2 are the same or different, and each represents 0 or 1].

HYDROXYL GROUP-CONTAINING MALEIMIDE COMPOUND

PROBLEM TO BE SOLVED: To provide a new hydroxyl group-containing maleimide compound excellent in a cure rate of an epoxy resin. SOLUTION: Provided are a maleimide compound having phenolic hydroxyl groups at 2-position and 6-position; a composition contain

Co-based heterogeneous catalysts from well-defined Α-diimine complexes: Discussing the role of nitrogen

Ar-BIANs and related α-diimine Co complexes were wet impregnated onto Vulcan XC 72 R carbon black powder and used as precursors for the synthesis of heterogeneous supported nanoscale catalysts by pyrolysis under argon at 800?°C. The catalytic materials feature a core-shell structure composed of metallic Co and Co oxides decorated with nitrogen-doped graphitic layers (NGr). These catalysts display high activity in the liquid phase hydrogenation of aromatic nitro compounds (110?°C, 50 bar H2) to give chemoselectively substituted aryl amines. The catalytic activity is closely related to the amount and type of nitrogen atoms in the final catalytic material, which suggests a heterolytic activation of dihydrogen.